中国临床保健杂志
中國臨床保健雜誌
중국림상보건잡지
CHINESE JOURNAL OF CLINICAL HEALTHCARE
2015年
4期
343-345
,共3页
代丽娟%朱晓明%刘春燕%刘葛%宋立群
代麗娟%硃曉明%劉春燕%劉葛%宋立群
대려연%주효명%류춘연%류갈%송립군
肾功能衰竭,慢性%黄芪%川芎嗪%水针
腎功能衰竭,慢性%黃芪%川芎嗪%水針
신공능쇠갈,만성%황기%천궁진%수침
Kidney failure,chronic%Astragalus membranaceus%Tetramethylpyrazine%Hydro-acupuncture
目的:观察黄芪联合川芎嗪交替穴位注射对慢性肾衰竭(CRF)非透析患者脾肾两虚、浊瘀内蕴者的临床疗效及对微炎症状态的影响,并探讨此疗法是否可作为辅助治疗 CRF 的有效方法之一加以推广。方法将符合纳入标准的80例患者采用随机数字表法平均分为治疗组和对照组,对照组仅予一般治疗,治疗组在对照组的基础上加用黄芪联合川芎嗪交替穴位注射,15 d 为1疗程,治疗周期为2个疗程,观察患者治疗前后血肌酐(Scr)、尿素(Bun)、尿酸(UA)、血红蛋白(Hb)、红细胞比容(Hct)及血清 C 反应蛋白(CRP)水平的变化。结果与同组治疗前相比,治疗组治疗后 Scr、BUN 及 CRP 显著下降(P <0.01),UA 有所下降(P <0.05),Hb、Hct 水平有所升高(P <0.05),对照组治疗后 Scr、BUN、UA 及 CRP 有所下降(P <0.05),Hb、Hct 水平有所升高(P <0.05)。治疗后治疗组 Scr、BUN 及 CRP 的效果优于对照组(P <0.05)。结论黄芪联合川芎嗪交替穴位注射辅助治疗可改善患者肾功能及微炎症状态,可为 CRF 的治疗提供一种有效方法。
目的:觀察黃芪聯閤川芎嗪交替穴位註射對慢性腎衰竭(CRF)非透析患者脾腎兩虛、濁瘀內蘊者的臨床療效及對微炎癥狀態的影響,併探討此療法是否可作為輔助治療 CRF 的有效方法之一加以推廣。方法將符閤納入標準的80例患者採用隨機數字錶法平均分為治療組和對照組,對照組僅予一般治療,治療組在對照組的基礎上加用黃芪聯閤川芎嗪交替穴位註射,15 d 為1療程,治療週期為2箇療程,觀察患者治療前後血肌酐(Scr)、尿素(Bun)、尿痠(UA)、血紅蛋白(Hb)、紅細胞比容(Hct)及血清 C 反應蛋白(CRP)水平的變化。結果與同組治療前相比,治療組治療後 Scr、BUN 及 CRP 顯著下降(P <0.01),UA 有所下降(P <0.05),Hb、Hct 水平有所升高(P <0.05),對照組治療後 Scr、BUN、UA 及 CRP 有所下降(P <0.05),Hb、Hct 水平有所升高(P <0.05)。治療後治療組 Scr、BUN 及 CRP 的效果優于對照組(P <0.05)。結論黃芪聯閤川芎嗪交替穴位註射輔助治療可改善患者腎功能及微炎癥狀態,可為 CRF 的治療提供一種有效方法。
목적:관찰황기연합천궁진교체혈위주사대만성신쇠갈(CRF)비투석환자비신량허、탁어내온자적림상료효급대미염증상태적영향,병탐토차요법시부가작위보조치료 CRF 적유효방법지일가이추엄。방법장부합납입표준적80례환자채용수궤수자표법평균분위치료조화대조조,대조조부여일반치료,치료조재대조조적기출상가용황기연합천궁진교체혈위주사,15 d 위1료정,치료주기위2개료정,관찰환자치료전후혈기항(Scr)、뇨소(Bun)、뇨산(UA)、혈홍단백(Hb)、홍세포비용(Hct)급혈청 C 반응단백(CRP)수평적변화。결과여동조치료전상비,치료조치료후 Scr、BUN 급 CRP 현저하강(P <0.01),UA 유소하강(P <0.05),Hb、Hct 수평유소승고(P <0.05),대조조치료후 Scr、BUN、UA 급 CRP 유소하강(P <0.05),Hb、Hct 수평유소승고(P <0.05)。치료후치료조 Scr、BUN 급 CRP 적효과우우대조조(P <0.05)。결론황기연합천궁진교체혈위주사보조치료가개선환자신공능급미염증상태,가위 CRF 적치료제공일충유효방법。
Objective To observe the clinical effects and influence of astragalus membranaceus combined li-gustrazine alternating point injection on slight inflammatory state in-into dialysis patients with chronic renal failure be-longed to deficiency of spleen and kidney and turbidity stasis intrinsic.Methods 80 cases included in the standard were randomly divided into treatment group and control group.The control group were given general treatment,and the treatment group were given treatment of astragalus membranaceus combined ligustrazine alternating point injec-tion on the basic of general treatment .All cases were under treatment for two courses,fifteen days was one treatment course.To observe the change of serum creatinine (Scr),blood urea (Bun),uric acid (UA),hemoglobin (Hb), red blood cells deposited (Hct),and serum C-reactive protein (CRP)in all cases before and after treatment.Re-sults Compared with pretreatment,the levels of Scr,BUN and CRP in the treatment group decreased significantly (P <0.01);UA was also decreased (P <0.05);but Hb and Hct increased (P <0.05)after the treatment.The lev-els of Scr,BUN,UA and CRP in the control group decreased (P <0.05);Hb and Hc were increased (P <0.05).Af-ter treatment,the improvements of Scr,BUN and CRP in the treatment group were better than those in the control group (P <0.05).Conclusion Astragalus membranaceus combined ligustrazine alternating point injection ,which improve renal function and slight inflammatory state in patients with chronic renal failure,would be an effective meth-od for the treatment of chronic renal failure.